Investigator

Yoshiaki Takagawa

Assistant doctor · Fukushima Medical University, Minimally Invasive Surgical and Medical Oncology

Research Interests

YTYoshiaki Takagawa
Papers(4)
Analysis of operative…Efficient workflow an…Laminaria tent insert…A novel dose-based in…
Collaborators(4)
Shinya KomoriTakahiro KatoAkihiko TakeuchiHiroki Sato
Institutions(2)
Fukushima Medical Uni…Southern Tohoku Gener…

Papers

Analysis of operative duration of image-guided brachytherapy for cervical cancer

The present study aimed to analyze the operative duration of image-guided brachytherapy (IGBT) for cervical cancer performed at our institution. We enrolled cervical cancer patients who had undergone tandem and ovoid-based intracavitary brachytherapy (ICBT) or intracavitary and interstitial brachytherapy (IC/ISBT) between 2020 and 2024. Cone beam computed tomography (CBCT), CT, or CT + MRI were used for IGBT. For each IGBT session, we retrospectively reviewed the following: application time (AT-defined as the duration from entry into the operating room to the initial image acquisition); planning time (PT-defined as the duration from the initial image acquisition to the start of irradiation); and total operation time (TOT- defined as the duration from entry to exit of the operating room). We analyzed a total of 126 sessions in 36 patients, consisting of 99 ICBT-only sessions and 27 IC/ISBT sessions. The IC/ISBT sessions had a significantly longer mean operative duration than the ICBT-only sessions. The IC/ISBT sessions with three or more interstitial needles had significantly longer AT and TOT. However, the IC/ISBT sessions with one needle showed no significant difference in operative duration compared to ICBT-only sessions. CBCT, CT, and CT + MRI were used in 42, 76, and 8 sessions, respectively. In the ICBT patients, CT + MRI had the longest PT. However, there was no significant differences in TOT among CBCT, CT, and CT + MRI. IC/ISBT sessions with one needle had no significant difference in operative duration compared to ICBT-only sessions. There was no significant difference in TOT between CT + MRI-based IGBT and CT-based IGBT.

Efficient workflow and clinical validation of in-house 3D-printed vaginal cylinders for high-dose-rate brachytherapy for gynecologic malignancies

This study developed an efficient methodology for in-house 3D-printed vaginal cylinders for gynecologic tumor treatment by evaluating their radiation attenuation, geometric accuracy, and efficacy. Ultimately, we aim to establish a simple, cost-effective approach that facilitates broad clinical adoption. Patient-specific vaginal cylinders were designed based on anatomical contours from the treatment planning system (TPS) using CAD software. The process was optimized to minimize manpower and time costs. Radiation attenuation of the 3D printer material was compared with that of water using the Monte Carlo method. Geometric accuracy was automatically analyzed via an in-house MATLAB program. Efficacy was assessed in cases of postoperative vaginal stump recurrence and vaginal cancer with paravaginal invasion. The tumor shape, delineated by TPS, was imported into CAD software, and the catheter pathway model, designed via subtraction processing, was placed at the optimal position and angle. The design process took approximately 15 min, and the entire workflow was completed within a week, demonstrating its practicality for clinical use. The radiation attenuation error was < 3% compared with water, and the geometric accuracy error was < 0.2 mm. The patient-specific vaginal cylinder provided a favorable dose distribution and was effective in complex cases. A feasible workflow was established, allowing in-house design and manufacturing with reduced manpower and time costs. With no material or processing issues, this approach is safe, practical, and promising for widespread adoption in personalized brachytherapy.

19Works
4Papers
4Collaborators
Vaginal NeoplasmsHead and Neck NeoplasmsLaryngeal NeoplasmsNecrosisNeoplasm Recurrence, LocalSquamous Cell Carcinoma of Head and Neck

Positions

2021–

Assistant doctor

Fukushima Medical University · Minimally Invasive Surgical and Medical Oncology

2021–

Doctor in Chief

Southern Tohoku Proton Therapy Center · Radiation Oncology

2019–

Researcher

Tokyo Metropolitan Tama Medical Center · Radiology

2017–

Chief Resident

National Cancer Centre · Radiation Oncology

2016–

Researcher

Saitama Hospital · Radiology

2016–

Faculty

Keio University Hospital · Radiation Oncology

2015–

Researcher

National Tokyo Medical Center · Radiation Oncology

2014–

Researcher

Kawasaki Municipal Hospital · Radiation Oncology

2014–

Researcher

Ofuna Chuo Byoin · Radiation Oncology

2012–

Senior Resident

Keio University Hospital · Radiology

2010–

Resident

National Tokyo Medical Center

Country

JP

Keywords
Radiation OncologyBrachytherapyFukushima